Navigation Links
Veteran Drug Industry Executive to Become President of CTI
Date:4/23/2008

New Leadership Completes CTI's Transformation to Commercial Operating

Business

SEATTLE, April 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq: CTIC; MTAX) today announced that Craig W. Philips, most recently Vice President and General Manager of Bayer Healthcare Oncology, has been named President of CTI with direct responsibilities for all Development and Commercial Operations, effective August 1, 2008. Philips' responsibilities will center on strategic management of oncology drug development, drug sales and marketing, medical affairs, science, and finance in the U.S. and in Europe. Philips will report to James Bianco, M.D., CTI's current President and CEO whose title will change to CEO upon Philips' employment with the Company.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080424/AQTH064)

"Craig Philips has a record of success in global oncology development and commercial operations. In his most recent role he was responsible for an operation in excess of $350 million. He will play a key role in CTI's transition from a research-stage company to an integrated commercial cancer drug operation," said Bianco. "We have made a significant investment in our cancer drug pipeline which is now poised to seek multiple product approvals and potentially drive significant sales growth. We believe this is the right time to bring on a seasoned executive like Craig."

CTI currently markets Zevalin(R) in the U.S., a drug for treating relapsed follicular non-Hodgkin's lymphoma (NHL), has submitted an application for approval for its lung cancer drug XYOTAX(TM) in Europe, and expects final data on anothe
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. New Technology for Early Detection of Lung Cancer Selected for Clinical Study With Veterans
2. Biomoda and Medical Acoustics Partner in Study for Early Detection of Lung Cancer in Veterans
3. Escalon(R) Announces Promotion of Industry Veteran Barry Durante to President of Sonomed, Inc.
4. Homewatch CareGivers Launches 2007 We Care For Veterans Campaign
5. Startech Environmental to Have Three Plasma Converters in Former Pharmaceutical Industry Facility in Puerto Rico
6. Another industry first enabled by Benchmark Biolabs - Peros oral delivery platform and vaccine facility licensed by the USDA
7. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
8. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
9. Life Science Executive Exchange 2008 To Sponsor Industry Awards
10. Ohio Task Force Begins Mission of Creating a New 21st Century Industry
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
... Sept. 18 Ingenuity Systems, the,leading provider...cientific,literature and data, is pleased to annou... major public-private biomedical research,partners...biological,markers to support new drug development...he founding members of the Consortium include the ...
...er 18 - Clinical Study Demonstrates Breakthrough... Capacities and Expands Potential Production,Capac... Sanofi pasteur, the vaccines division of sanofi-...ts new investigational H5N1 pandemic influenza,vac...high immune response,at the lowest dose of H5N1 an...
...e University of Pennsylvania have developed nanowi...ears and retrieving that data a thousand times fas...Flash memory and micro-drives, all using less powe...tesh Agarwal, an assistant professor in the Depart...leagues developed a self-assembling nanowire of ge...
Other Biology Technology:Ingenuity Systems Joins Biomarkers Consortium 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
(Date:12/2/2009)PHILADELPHIA People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smo
(Date:12/2/2009)PHILADELPHIA Exposure to secondhand smoke for a prolonged period of time and in high quantity may increase the risk of breast cancer, even in women who never smoked cigarettes themselves. , "The qu
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2The Wonder 28R 29 You Love Now Offers Even More of the Nutrition You Need Wonder Classic and Wonder Classic Sandwich Provide Even More Calcium and N 54290 1The Wonder 28R 29 You Love Now Offers Even More of the Nutrition You Need Wonder Classic and Wonder Classic Sandwich Provide Even More Calcium and N 54290 2Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 1Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 2Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 3Midbrook Pushes for Innovation in Medical Decontamination 54284 1Midbrook Pushes for Innovation in Medical Decontamination 54284 2Midbrook Pushes for Innovation in Medical Decontamination 54284 3
... all recommended flu vaccine appear to be less lik...timates hospitalizes 20,000 children every year. ,...Pediatrics by the University of Rochester Medical...nths (the youngest able to receive the vaccine) an...y found that, even though those years had poor mat...
...ly cause human blood and plasma to clota process t...g the course of vertebrate evolution, according to...al Institute of Allergy and Infectious Diseases, a...be published online Nov. 2 in Nature Chemical Bio...derstanding of coagulation during bacterial infect...
... universities, and inventors designing and manufac...ted economy will radically change over the next de...growing fieldknown as bioelectronicsfrom nine expe...8, from 4:45-6 p.m., in room 202, of the Electrica...ren St, at the northwest corner of Summit and Warr...
Other Biology News:Flu shot protects kids -- even during years with a bad vaccine match 2Nature study demonstrates that bacterial clotting depends on clustering 2NJIT seminar set for Nov. 6 to focus on bioelectronics -- emerging research area 2
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
Feline IL-5, Unconjugated from R&D Systems
...ess Cloning Checker Kits provide two highly effici...ter transformation without time-consuming plasmid ...d in Kit I, all you need to do is to transfer part... transformation plates into the solutions provided...
Biology Products: